Mart Ustav
Profile
Mart Ustav, who previously worked as the Chief Executive Officer of Icosagen AS and Icosagen Cell Factory Ltd., also served as the Chief Scientific Officer of FIT Biotech Oy from 2014 to 2016.
Additionally, he worked as a Professor at the University of Tartu.
Former positions of Mart Ustav
| Companies | Position | End |
|---|---|---|
| Icosagen Cell Factory Ltd. | Chief Executive Officer | - |
| University of Tartu | Corporate Officer/Principal | - |
Icosagen AS
 Icosagen AS Pharmaceuticals: MajorHealth Technology Icosagen AS is a biotechnology company based in Tartu, Estonia. Established in 1999, the Estonian company offers contract research, development, and manufacturing services to biotechnology and pharmaceutical companies. With a team of over 190 experts, Icosagen specializes in discovering and producing recombinant proteins and antibodies. The private company comprises four entities, including Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and Icopark OÜ. Icosagen provides antibody discovery and development services, food microbiology testing, and GMP-compliant high productivity CHO-based stable cell line development. The company collaborates with Future Style to offer its antigens and antibodies. Icosagen also supports functional activity testing of products in suitable cell-based activity assays. | Chief Executive Officer | - |
| FIT BIOTECH OY | Chief Tech/Sci/R&D Officer | 31/12/2015 |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
FIT Biotech Oy
 FIT Biotech Oy BiotechnologyHealth Technology FIT Biotech Oy engages in the business of researching, developing, and manufacturing diagnostic laboratory tests and pharmaceutical products. The firm is also involved in marketing gene transport unit vector technology to be used as a gene transport mechanism in gene therapeutic applications. The company was founded on May 17, 1995 and is headquartered in Tampere, Finland. | Health Technology |
Icosagen AS
Icosagen AS Pharmaceuticals: MajorHealth Technology Icosagen AS is a biotechnology company based in Tartu, Estonia. Established in 1999, the Estonian company offers contract research, development, and manufacturing services to biotechnology and pharmaceutical companies. With a team of over 190 experts, Icosagen specializes in discovering and producing recombinant proteins and antibodies. The private company comprises four entities, including Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and Icopark OÜ. Icosagen provides antibody discovery and development services, food microbiology testing, and GMP-compliant high productivity CHO-based stable cell line development. The company collaborates with Future Style to offer its antigens and antibodies. Icosagen also supports functional activity testing of products in suitable cell-based activity assays. | Health Technology |
| Icosagen Cell Factory Ltd. |
- Stock Market
- Insiders
- Mart Ustav
